This partnership highlights Profarma’s dedication to advancing biotechnology and encouraging collaborative efforts within the industry.

By joining Lithuania Bio, Profarma aims to contribute to the vibrant biotechnology community in Lithuania, leveraging the association’s platform to engage in meaningful partnerships, knowledge sharing, and joint initiatives. Lithuania Bio, renowned for its role in promoting the life sciences sector, provides a robust network and a wealth of resources that will support Profarma in its mission to drive scientific progress and improve patient outcomes.

“We are thrilled to become a member of Lithuania Bio,” said Dr. Edita Griniute, CEO of Profarma. “This membership aligns perfectly with our strategic vision of innovation and collaboration. We believe that by working together with other industry leaders and stakeholders, we can accelerate the development of cutting-edge biotechnological solutions and make a significant impact on healthcare both locally and globally.”

As a member of Lithuania Bio, Profarma will actively participate in various industry events, conferences, and forums. The company looks forward to contributing to policy discussions, research collaborations, and educational initiatives that will shape the future of biotechnology in Lithuania and beyond.

Contact:

info@profarma.lt